OCREB Governance Committee
The Ontario Cancer Research Ethics Board (OCREB) was introduced in December 2003 in response to a need to improve and streamline ethics reviews of multi-centre oncology research. OCREB’s primary responsibility is to protect the safety and rights of human research participants. OCREB serves as an expert oncology research ethics board for 28 of the 29 hospitals in Ontario that conduct multi-centre cancer trials. OCREB is a program of the Ontario Institute for Cancer Research (OICR), and it is an independent body operating at arm’s length from programmatic and research structures within the OICR. OCREB is accountable to the OICR Board of Directors through the OICR and OCREB Governance Committees.
Division Head, Radiation Oncology
Associate Professor, Department of Oncology, McMaster University
Dr. Jim Wright is Chair of OCREB Governance Committee and Head, Integrated Radiation Treatment Program at the Juravinski Cancer Centre (JCC) in Hamilton. He completed his undergraduate degree at the University of Guelph and his subsequent medical degree, radiation oncology residency, and Master’s in Epidemiology all at McMaster University. Dr Wright is an active member of the head and neck and lung disease site groups at the JCC. He is an active collaborator on many clinical and translational research trials and grants, and has an interest in Health Services Research, specifically in the area of clinical trials. He is currently the Chair of the CCTG’s Data Safety Monitoring Committee, and prior to his role in the Radiation Treatment Program, he was the head of the Clinical Trials Department at the JCC for 10 years.
Partner, First Canadian Investment Properties
Managing Partner at Cathcart & Associates
Partner at First Canadian Investment Properties and Managing Partner at Cathcart & Associates. Derek Cathcart became associated with First Canadian in December 2006 after holding senior management positions with domestic and global financial institutions in corporate/investment banking including TD Financial Group and ABN AMRO. Derek has extensive experience in corporate lending, investment banking and proprietary investing activities in Canada, USA, Europe, New Zealand and Australia. He specializes in advising clients on limited recourse project finance (including 3P), mergers/acquisitions and divestitures in industries ranging from owner-managed businesses to multinational companies with respect to debt and equity financings, restructurings, business and securities valuations and fairness opinions. Derek is a graduate of University of Western Ontario’s Richard Ivey School of Business, where he received an Honours BBA and an MBA. In addition, Derek is an active member of the University Health Network Research Ethics Board as well as having earned the Certified Management Accountant (Ontario) designation.
Director, Research Ethics, University of British Columbia
Founder and President, Henley Capital Corporation
Mr. Henley is the founder and President of Henley Capital Corporation, a registered Exempt Market Dealer and Portfolio Manager. He has spent over 30 years in industry and investment banking financing and advising public and private companies covering the full range of industry sectors and market capitalizations and was formerly an officer at three of Canada’s largest investment banking firms. Mr. Henley serves on a number of charitable, industry and public and private company boards and is currently Chair of West Park Healthcare Centre in Toronto and Chair of the McMichael Canadian Art Foundation and is a board member of Transition Therapeutics Inc. Mr. Henley has also served as Chair of the Judging Panel of the Canadian Software and IT Services Industry Awards, was a founding Co-Chair of the Premier’s Technology Dinner in Ontario, a founding member of the Ministers Technology Advisory Group for the Province of Ontario and a founding 100 member of the National Angel Organization in Canada. He is a former board member and Chair of the Toronto Port Authority, a former board member of the Exempt Market Dealers Association of Canada, a former director of Ontario Transport Capital Corporation — the developer of Highway 407, the first all-electronic highway in the world; and a past member of the Advisory Board, Faculty of Business Administration, Memorial University of Newfoundland. Mr. Henley is also actively involved in a number of annual charitable events and is a founding director and Vice-Chair of the Future Focus Foundation and the Smiling Land Foundation. Mr. Henley holds a BA from Memorial University, an MBA from Dalhousie University and has completed the Institute of Corporate Directors Education Program at the Rotman School of Management in Toronto. In 2006, Mr. Henley received the internationally recognized professional designation, ICD.D.